The theory behind leucovorin's use for autism postulates that some children have a blockage in the transport of folic acid ...
Some e-cigarette companies targeted by U.S. authorities have altered their business model or changed their corporate ...
An off-label prescription drug has been shown to help some non ... as a potential treatment for people with autism, larger controlled clinical trials are needed to determine its efficacy and ...
An off-label prescription drug has been shown to help children with autism gain the ability to speak. Leucovorin is used for cancer patients, but doctors are pushing for its approval for autism.
Rapid Initiation Protocol Reduces Time to Treatment with SUBLOCADE® From One Week to One Hour, A Significant Advancement in the Treatment of Moderate to Severe Opioid ...
AMLX has had major setbacks in its lifecycle, including the voluntary withdrawal of an approved drug. Click here to find out ...
Entrada Therapeutics (TRDA) announced that the United States Food and Drug Administration has lifted the clinical hold on ENTR-601-44 and ...
Pharmaceutical Technology on MSN5d
Supernus’s stock sinks after depression drug fails trialThe company announced on 18 February that the trial did not meet its primary endpoint measured by a depression rating scale, ...
A systematic review confirmed the safety and efficacy of a pulsed dye laser for the treatment of port-wine birthmarks and infantile hemangiomas.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback